MALAT1 Knockdown Inhibits the Proliferation, Migration, and Collagen Deposition of Human Hypertrophic Scar Fibroblasts via Targeting miR-29a-3p/Smurf2 Axis
DOI: https://doi.org/10.2147/ccid.s460845
2024-06-13
Clinical Cosmetic and Investigational Dermatology
Abstract:Chunyan Guo, 1, 2, &ast Xiaoxiao Liu, 1, &ast Keqing Qiu, 2 Longxiang Tu, 1 Dewu Liu 1 1 Medical Center of Burn Plastic and Wound Repair, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, People's Republic of China; 2 Department of Dermatology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, People's Republic of China &astThese authors contributed equally to this work Correspondence: Dewu Liu, Email Purpose: Hypertrophic scarring (HS) is commonly described as an abnormal post-traumatic tissue repair characterized by excessive hypercellularity and extracellular matrix (ECM) deposition. Mounting evidence suggests that MALAT1 is maladjusted in many fibrotic diseases, but its contribution to HS progression remains poorly understood. Hence, we sought to elucidate the fundamental role of MALAT1 in HS. Methods: The expression of MALAT1, miR-29a-3p, and Smurf2 in skin tissues and fibroblasts was assessed by RT-qPCR and Western blotting. Furthermore, lentiviruses, RNAi, or plasmids were utilized to transfect hypertrophic scar fibroblasts (HSFs) for gene overexpression or downregulation. The biological behaviors of HSFs were quantified by the CCK-8 assay, wound healing assay, transwell assay, and flow cytometry. Mechanistically, bioinformatics analysis, dual-luciferase reporter assays, and rescue experiments were performed to verify the relationship between miR-29a-3p and MALAT1 or Smurf2. Results: Our data indicate that MALAT1, Smurf2 were overexpressed while miR-29a-3p was suppressed in HS tissues and fibroblasts. Downregulation of MALAT1 may lead to decreased proliferation, migration, and invasion of fibroblasts, accompanied by enhanced apoptosis, reduced TGF-β signal transduction, and ECM accumulation in HSFs, by enhancing miR-29a-3p and suppressing Smurf2 expression. Mechanistically, MALAT1 acted as a sponge for miR-29a-3p, while miR-29a-3p directly targeted Smurf2. More importantly, rescue experiments suggested that MALAT1 downregulation induced impact on the proliferation, migration, and invasion of HSFs could be partially overturned through miR-29a-3p knockdown or Smurf2 overexpression. Conclusion: MALAT1 knockdown inhibits the proliferation, migration, invasion, and collagen deposition of HSFs via targeting the miR-29a-3p/Smurf2 axis, which may reveal a promising therapeutic exploitable vulnerability to HS. Keywords: hypertrophic scar, fibroblasts, MALAT1, miR-29a-3p, Smurf2, TGF-β signaling pathway Graphical Hypertrophic scarring (HS) is characterized by a fibroproliferative disorder resulting from an irregular healing process triggered by trauma, burns, surgery, skin ailments etc. 1 HS can result in intense itching, pain, and contracture, negatively affecting the physical and psychological well-being of patients. 2 The pathological processes underlying HS are intricate and not fully understood. At present, prophylactic and treatment strategies such as topical silicone gel, corticosteroid injections, pressure therapy, laser therapy, and surgical excision remain unsatisfactory, leaving HS with a high recurrence rate, which is a difficult problem in clinical practice. 3–5 Thus, further investigation of the detailed mechanisms and identification of new effective therapeutic agents for HS are crucial for the management of this condition. LncRNAs are a subgroup of RNAs greater than 200 nucleotides in length that have little or no protein-coding capacity. Increasing evidence suggests that lncRNAs are involved in a series of biological processes including development, differentiation, and metabolism, 6 and can exert their functions by sponging microRNAs (miRNAs). 7 In addition, lncRNAs have been shown to play critical roles in the development of HS. 8 Among the numerous lncRNAs, MALAT1, one of the most extensively studied, has drawn our attention and has been documented to participate in various fibrotic conditions including liver fibrosis, 9 renal fibrogenesis, 10 cardiac fibrosis, 11 and skin fibrosis. 12 Hence, considering fibrosis as the primary pathological mechanism of HS, our hypothesis suggests a potential association between MALAT1 expression and HS progression. However, MALAT1 is not completely understood in terms of its biological functions and underlying mechanisms in HS. MicroRNAs (miRNAs) are a class of RNAs that without protein-coding ability, and are typically composed of approximately 21–23 nucleotides. Generally, miRNAs can hinder translation or enhance the breakdown of target gene -Abstract Truncated-
dermatology